Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra J Sinclair

Showing results (51-60 of 113) with videos related to

Pageof 12
Sort By:
BMJ Open|June 1, 2018
Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online surveyWilliam J Scotton, Susan P Mollan, Thomas Walters, et al.
Endocrine Reviews|April 25, 2013
11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspectsLaura L Gathercole, Gareth G Lavery, Stuart A Morgan, et al.
Cephalalgia : an International Journal of Headache|June 19, 2018
Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?Andreas Yiangou, James Mitchell, Keira Annie Markey, et al.
The Journal of Headache and Pain|May 21, 2025
Unravelling the gut-brain connection: a systematic review of migraine and the gut microbiomeCaroline W Mugo, Ella Church, Richard D Horniblow, et al.
Eye (London, England)|January 18, 2024
A systematic review of optical coherence tomography findings in adults with mild traumatic brain injuryHannah S Lyons, Matilde Sassani, Yousef Hyder, et al.
Journal of Neuroinflammation|July 9, 2025
A systematic review of the causes and consequences of spreading depolarization in neuroinflammation; implications for neurovascular disordersFaheem Anwar, Olivia Grech, Caroline W Mugo, et al.
Eye (London, England)|January 11, 2024
Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial HypertensionOlivia Grech, James L Mitchell, Hannah S Lyons, et al.
Neuro-Ophthalmology (Aeolus Press)|December 15, 2017
What Do Transgender Patients Teach Us About Idiopathic Intracranial Hypertension?Catherine Hornby, Susan P Mollan, James Mitchell, et al.
British Journal of Pharmacology|September 23, 2023
Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibitionCristina Gómez, Zerin Alimajstorovic, Nantia Othonos, et al.
NMR in Biomedicine|August 20, 2009
NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases--a diagnostic tool?Alexandra J Sinclair, Mark R Viant, Alexandra K Ball, et al.
Pageof 12

Showing results (51-60 of 113) with videos related to

Sort By:
Pageof 12
BMJ Open|June 1, 2018
Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online surveyWilliam J Scotton, Susan P Mollan, Thomas Walters, et al.
Endocrine Reviews|April 25, 2013
11β-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspectsLaura L Gathercole, Gareth G Lavery, Stuart A Morgan, et al.
Cephalalgia : an International Journal of Headache|June 19, 2018
Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?Andreas Yiangou, James Mitchell, Keira Annie Markey, et al.
The Journal of Headache and Pain|May 21, 2025
Unravelling the gut-brain connection: a systematic review of migraine and the gut microbiomeCaroline W Mugo, Ella Church, Richard D Horniblow, et al.
Eye (London, England)|January 18, 2024
A systematic review of optical coherence tomography findings in adults with mild traumatic brain injuryHannah S Lyons, Matilde Sassani, Yousef Hyder, et al.
Journal of Neuroinflammation|July 9, 2025
A systematic review of the causes and consequences of spreading depolarization in neuroinflammation; implications for neurovascular disordersFaheem Anwar, Olivia Grech, Caroline W Mugo, et al.
Eye (London, England)|January 11, 2024
Effect of glucagon like peptide-1 receptor agonist exenatide, used as an intracranial pressure lowering agent, on cognition in Idiopathic Intracranial HypertensionOlivia Grech, James L Mitchell, Hannah S Lyons, et al.
Neuro-Ophthalmology (Aeolus Press)|December 15, 2017
What Do Transgender Patients Teach Us About Idiopathic Intracranial Hypertension?Catherine Hornby, Susan P Mollan, James Mitchell, et al.
British Journal of Pharmacology|September 23, 2023
Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibitionCristina Gómez, Zerin Alimajstorovic, Nantia Othonos, et al.
NMR in Biomedicine|August 20, 2009
NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases--a diagnostic tool?Alexandra J Sinclair, Mark R Viant, Alexandra K Ball, et al.
Pageof 12